Group One Trading’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151K Buy
18,149
+11,109
+158% +$115K 0.01% 4355
2025
Q4
$87K Sell
7,040
-89,240
-93% -$956K ﹤0.01% 5115
2025
Q3
$849K Buy
96,280
+13,470
+16% +$105K 0.03% 3197
2025
Q2
$528K Buy
+82,810
New +$474K 0.02% 3361
2025
Q1
Sell
-37,609
Closed -$311K 8122
2024
Q4
$360K Sell
37,609
-8,000
-18% -$73.4K 0.01% 3441
2024
Q3
$381K Buy
+45,609
New +$415K 0.02% 3066
2024
Q2
Hold
0
7222
2024
Q1
Sell
-273,774
Closed -$617K 7545
2023
Q4
$657K Buy
273,774
+83,133
+44% +$195K 0.02% 2840
2023
Q3
$648K Buy
190,641
+188,920
+10,977% +$1.05M 0.03% 2664
2023
Q2
$12.6K Buy
1,721
+1,389
+418% +$12.9K ﹤0.01% 6263
2023
Q1
$3.44K Sell
332
-10,629
-97% -$128K ﹤0.01% 6441
2022
Q4
$129K Buy
10,961
+8,844
+418% +$137K ﹤0.01% 4211
2022
Q3
$44K Sell
2,117
-6,200
-75% -$173K ﹤0.01% 5500
2022
Q2
$258K Buy
8,317
+3,414
+70% +$117K 0.01% 4051
2022
Q1
$201K Sell
4,903
-6,211
-56% -$274K ﹤0.01% 4795
2021
Q4
$483K Sell
11,114
-8,459
-43% -$383K 0.01% 4173
2021
Q3
$980K Buy
19,573
+3,300
+20% +$200K 0.02% 3438
2021
Q2
$1.02M Buy
16,273
+12,005
+281% +$771K 0.02% 3389
2021
Q1
$397K Sell
4,268
-10,386
-71% -$1.06M 0.01% 4302
2020
Q4
$1.31M Sell
14,654
-12,874
-47% -$1.18M 0.04% 2402
2020
Q3
$2.84M Buy
+27,528
New +$2.97M 0.13% 1313
2020
Q2
Hold
0
6071
2018
Q4
Sell
-200
Closed -$13K 5116
2018
Q3
$13K Buy
+200
New +$11.7K ﹤0.01% 4566
2017
Q4
Hold
0
5035
2017
Q3
Sell
-2,500
Closed -$90.5K 5008
2017
Q2
$85K Buy
+2,500
New +$77.2K 0.01% 3208
2017
Q1
Sell
-1,400
Closed -$46K 4806
2016
Q4
$46K Buy
1,400
+1,300
+1,300% +$39K ﹤0.01% 3304
2016
Q3
$3K Sell
100
-1,100
-92% -$32K ﹤0.01% 4295
2016
Q2
$34K Buy
+1,200
New +$47K ﹤0.01% 3538

Other funds holding EBS